Lantern Pharma Inc. (LTRN)
NASDAQ: LTRN · Real-Time Price · USD
3.380
+0.100 (3.05%)
Nov 7, 2024, 1:26 PM EST - Market open
Lantern Pharma Employees
Lantern Pharma had 21 employees as of December 31, 2023. The number of employees decreased by 2 or -8.70% compared to the previous year.
Employees
21
Change (1Y)
-2
Growth (1Y)
-8.70%
Revenue / Employee
n/a
Profits / Employee
-$845,128
Market Cap
36.38M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Concord Medical Services Holdings | 727 |
Neuronetics | 203 |
Celularity | 120 |
NextCure | 82 |
BioLineRx | 79 |
Curis | 49 |
Surrozen | 42 |
Lumos Pharma | 33 |
LTRN News
- 2 days ago - Starlight Therapeutics Announces Inaugural Members of Scientific Advisory Board - Business Wire
- 7 days ago - Lantern Pharma to Report Third Quarter 2024 Operating & Financial Results on November 7th, 2024 at 4:30 p.m. ET - Business Wire
- 15 days ago - Lantern Pharma to Present at the ThinkEquity Conference in NYC on October 30, 2024 - Business Wire
- 17 days ago - Lantern Pharma to Host & Participate in Two Public Webinars During October - Business Wire
- 23 days ago - Lantern Pharma's Investigational Drug-Candidate, LP-184, Receives Fast-Track Designation in Glioblastoma from the FDA - Business Wire
- 6 weeks ago - Lantern Pharma Announces Three U.S. FDA Rare Pediatric Disease Designations Granted to LP-184 in Multiple Ultra Rare Children's Cancers - Business Wire
- 3 months ago - Lantern Pharma Inc. (LTRN) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Lantern Pharma Reports Second Quarter 2024 Financial Results and Business Updates - Business Wire